Yingrui Shi

Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)

Yunpeng Yang, Ting Zhou, Xiaozhong Chen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Quercetin inhibits neuronal Ferroptosis and promotes immune response by targeting lipid metabolism-related gene PTGS2 to alleviate breast cancer-related depression

Qing Zhu, Yuanshan Han, Ying He et al. · Phytomedicine · 2024 · 48 citations

Life Sciences, Neuroscience, Pharmacology +8

Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways

Dehua Liao, Danggang Shangguan, Yi Wu et al. · Psychopharmacology · 2023 · 44 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC).

Rui‐Hua Xu, Hai‐Qiang Mai, Qiuyan Chen et al. · Journal of Clinical Oncology · 2021 · 36 citations

Medicine, Oncology, Pharmacotherapy +15

RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer

Shiming Tan, Pin Yi, Heran Wang et al. · Frontiers in Oncology · 2020 · 29 citations · Full text

Medicine, Cancer Biology, Oncology +16